Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 13Prostatic Neoplasms 11Kidney Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 3Wilms Tumor 2Carcinoma, Renal Cell 2Urologic Neoplasms 1Urethral Neoplasms 1Testicular Neoplasms 1Teratoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Prostate CA 1Prostate Adenocarcinoma 1Pain, Postoperative 1Pain 1Ovarian Germ Cell Cancer 1Oligometastatic Renal Cell Carcinoma 1Neoplasms, Second Primary 1Neoplasms 1Neoplasm Metastasis 1Muscle Invasive Bladder Cancer 1Lung Neoplasms 1Endodermal Sinus Tumor 1Directly Observed Therapy 1Carcinoma, Transitional Cell 1Adenocarcinoma 1Acute Kidney Injury 1

Interventions

Gemcitabine 24Cisplatin 18Carboplatin 10Paclitaxel 9Specimen Handling 6Nivolumab 6Doxorubicin 6Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5cabozantinib 4avelumab 4Vinblastine 4Radiotherapy 4Methotrexate 4Fluorouracil 4enfortumab vedotin 3atezolizumab 3aflibercept 3Trastuzumab 3Sunitinib 3Ramucirumab 3Platinum 3Ipilimumab 3CTLA-4 Antigen 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3vinflunine 2pegfilgrastim 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urethral Neoplasms × Surgical Procedures, Operative × Genitourinary × Clear all
NCT00045630 2013-05-27

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

SWOG Cancer Research Network

Phase 2 Completed
77 enrolled 11 charts
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡